Organ_On_A_Chip_Teaser

Organs-on-Chips: An Alternative to 3D Bioprinting?

While 3D Printing has attracted a great deal of attention from investors because of high growth projections, 3D Bioprinting has attracted investors because of its futuristic appeal. Some companies involved in 3D Bioprinting are raising eyebrows with their lofty ambitions, like private company Modern Meadow which is looking to 3D Print leather, or publicly traded Organovo (NYSEMKT:ONVO) which hopes one day to be able to print human organs for transplant. The reality is though, that neither of these companies are anywhere near being able to 3D Bioprint at a size or economic scale to realize these aspirations. A more near-term use for 3D Bioprinting is to create small samples of organ tissues that can potentially be used for drug testing. Organovo plans to launch its upcoming 3D Human Liver Tissue before the end of 2014, and there are many other companies involved in 3D Bioprinting that could look to enter this space [...]

Solar3D_Teaser

Solar3D: Can They Really Revolutionize Solar?

When evaluating investing opportunities in disruptive technologies, it is equally as important to identify what one should not invest in as it is to identify what one should invest in. In a past article, we discussed the potential dangers of investing in over-the-counter (OTC) stocks and throughout the past year have pointed out many examples of OTC companies attaching themselves to the latest disruptive technology with big promises and little in the way of progress. One OTC company that has generated a great deal of attention lately is Solar3D.       Solar3D  Originally formed in January 2002 as MachineTalker, the Company started out pursuing the development of a new wireless process control technology. In mid-2010, the Company was renamed to Solar3D (OTCMKTS:SLTD) and then shifted engineering and research focus towards developing highly efficient solar cells. Solar3D claims that [...]

Organ_On_A_Chip_Teaser

Organs-on-Chips: An Alternative to 3D Bioprinting?

While 3D Printing has attracted a great deal of attention from investors because of high growth projections, 3D Bioprinting has attracted investors because of its futuristic appeal. Some companies involved in 3D Bioprinting are raising eyebrows with their lofty ambitions, like private company Modern Meadow which is looking to 3D Print leather, or publicly traded Organovo (NYSEMKT:ONVO) which hopes one day to be able to print human organs for transplant. The reality is though, that neither of these companies are anywhere near being able to 3D Bioprint at a size or economic scale to realize these aspirations. A more near-term use for 3D Bioprinting is to create small samples of organ tissues that can potentially be used for drug testing. Organovo plans to launch its upcoming 3D Human Liver Tissue before the end of 2014, and there are many other companies involved in 3D Bioprinting that could look to enter this space [...]

FEIC_Teaser

FEIC: Supplying the Picks and Shovels for Nanotechnology

In the 1850s during the time of the gold rush, one businessman realized he could make the same amount of money from the gold boom with far less risk by selling essentials to the miners as opposed to engaging in the risky practice of gold mining like others. Levi Strauss was his name, and went on to amass a fortune of about $163 million in today's money with his world-renound blue jeans company remaining in business still today. About 10 years ago when nanotechnology was becoming hyped throughout the investment community as the next greatest thing, one company that was often mentioned by pundits as supplying the "picks and shovels" to the development of nanotechnology was FEI Corporation (NASDAQ:FEIC). While most of the companies in the now discontinued Merrill Lynch Nanotechnology Index couldn't even manage to beat the S&P 500 returns over the past ten years, FEI was one of the four companies that [...]

FEIC_Teaser

FEIC: Supplying the Picks and Shovels for Nanotechnology

In the 1850s during the time of the gold rush, one businessman realized he could make the same amount of money from the gold boom with far less risk by selling essentials to the miners as opposed to engaging in the risky practice of gold mining like others. Levi Strauss was his name, and went on to amass a fortune of about $163 million in today's money with his world-renound blue jeans company remaining in business still today. About 10 years ago when nanotechnology was becoming hyped throughout the investment community as the next greatest thing, one company that was often mentioned by pundits as supplying the "picks and shovels" to the development of nanotechnology was FEI Corporation (NASDAQ:FEIC). While most of the companies in the now discontinued Merrill Lynch Nanotechnology Index couldn't even manage to beat the S&P 500 returns over the past ten years, FEI was one of the four companies that [...]

Lastest Articles

Solar3D_Teaser

Solar3D: Can They Really Revolutionize Solar?

When evaluating investing opportunities in disruptive technologies, it is equally as important to identify what one should not invest in as it is to identify what one should invest in. In a past article, we discussed the potential dangers of investing in over-the-counter [...]

SunShare_Teaser

SunShare and “Community Solar Gardens”

Rooftop solar sounds like a great idea. You can have solar panels installed on your roof for no money up front and can not only power your house but also can potentially sell some of the electricity you generate back to the grid. But what if you don't have a suitable rooftop [...]

3D_Printing_Teaser

Nanotechnology Investing and Large Cap Companies

In a recent article, we highlighted the fact that the now discontinued Merrill Lynch Nanotechnology Index did not show investors superior returns when compared to the returns of the S&P 500 over the past ten years. This means that "nanotechnology investors" would have [...]